Back to search results

Centering Appetite for Type 2 Diabetes and Binge Eating

This study is testing a behavioral intervention called "Centering Appetite" to help African American adults with type 2 diabetes better manage their appetite and blood sugar. The intervention teaches you to recognize your body's hunger and fullness signals and helps you monitor your appetite. You'll also learn about managing your glucose (blood sugar) and carbohydrates. The study is looking at whether it's practical to recruit participants, how many attend sessions, and how well they stick with the program. To join, you must be an African American adult between 18 and 75 years old with an A1c (a measure of blood sugar over time) greater than 7.5, a working smartphone, and a history of binge eating. This study is currently recruiting participants.

Study design
This is an interventional study with 60 participants. You will be randomly assigned to either the "Centering Appetite" intervention group or a control group.
What's involved
If you are in the Centering Appetite group, you will have two intervention sessions, monthly booster sessions, and weekly messages over 6 months. You will also receive a Fitbit to monitor daily physical activity. The control group will also receive two intervention sessions and weekly nutrition tutorials.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 6 months after starting the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT05741125

Improving Appetite Self-Regulation in African American Adults With Type 2 Diabetes

Recruiting
NAAges 18–75InterventionalTreatment
University of North Carolina, Chapel Hill
~60 participants
Updated 2025-06-17 on ClinicalTrials.gov
What's tested:DSME + ASE intervention (Centering Appetite)

At a glance

Recruiting sites
1 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Feasibility (Recruitment): The Percentage of Participants Who Were Eligible and Enrolled in the Study at Baseline
Measured over Baseline
+5 more outcomes measured

Conditions

Type 2 Diabetes
Binge Eating

Explore related trials

Binge EatingType 2 Diabetes Mellitus

Where it's being run

2 sites across 1 states
North Carolina2

Study leadership

  • Rachel Goode, PhD, MPH, LCSW · PRINCIPAL_INVESTIGATOR · University of North Carolina at Chapel Hil

Who to contact

Ramine Alexander, PhD, MPH
[email protected]
704-250-5093
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

identify as a Non-Hispanic, AA
are over 18 years of age
have an A1c value \> 7.5
have a working Smartphone
complete binge eating screening

Exclusion

have major end-organ type 2 diabetes mellitus complications
have a history of weight loss surgery
are currently pregnant
in substance use treatment or are involved in another weight reduction program.

What this trial measures

  • Feasibility (Recruitment): The Percentage of Participants Who Were Eligible and Enrolled in the Study at BaselineBaseline

    The number of potential participants screened for study eligibility versus the number of persons who enrolled in the study.

  • Feasibility (Recruitment): The Percentage of Participants Who Were Eligible and Enrolled in the Study at Month 6Month 6

    The number of potential participants screened for study eligibility versus the number of persons who enrolled in the study.

  • Feasibility (Attendance): The Percentage of Participants who Enrolled and Attended Each Intervention SessionMonth 6

    The number of potential participants who attended intervention sessions versus the number of persons who enrolled in the study and did not attend intervention sessions.

  • Feasibility (Retention): The Percentage of Participants Retained in the Study at Month 6Month 6

    Percentage of participants retained in the study following enrollment.

  • Feasibility (Treatment Adherence): The Percentage of Participants Who Adhered to Study ProtocolMonth 6

    Percentage of participants who adheres to study protocol.

  • Acceptability (Satisfaction): The Percentage of Participants Who Were Satisfied with the Delivery and Content of the InterventionMonth 6

    Participant satisfaction will be measured using a self-report scale at month 6. The Acceptability of Intervention Measure (AIM), Intervention Appropriateness Measure (IAM). This is a 4-item scale with 1 being the lowest measure and 5 being the highest measure.